Xyzal and Fenoterol hydrobromide drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Xyzal (levocetirizine dihydrochloride) and Fenoterol hydrobromide (fenoterol hydrobromide). Common drug interactions include portal vein thrombosis among females and blount's disease among males.
The phase IV clinical study analyzes what interactions people have when they take Xyzal and Fenoterol hydrobromide. It is created by eHealthMe based on reports of 12 people who take the same drugs from the FDA, and is updated regularly.
What is Xyzal?
Xyzal has active ingredients of levocetirizine dihydrochloride. It is often used in allergies. eHealthMe is studying from 21,479 Xyzal users. Check the latest studies of Xyzal.
What is Fenoterol hydrobromide?
Fenoterol hydrobromide has active ingredients of fenoterol hydrobromide. eHealthMe is studying from 1,327 Fenoterol hydrobromide users. Check the latest studies of Fenoterol hydrobromide.
12 people who take Xyzal and Fenoterol hydrobromide together, and have interactions are studied.
What are the common drug interactions of Xyzal and Fenoterol Hydrobromide, by gender? *:
female:
- Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
- Arthralgia (joint pain)
- Joint swelling
- Loss of consciousness
- Muscle spasms (muscle contraction)
male:
- Blount's disease (growth disorder of the tibia (shin bone) that causes the lower leg to angle inward, resembling a bowleg)
- Cardiac arrest
- Procedural hypotension
- Respiratory failure (inadequate gas exchange by the respiratory system)
What are the common drug interactions of Xyzal and Fenoterol Hydrobromide, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Blount's disease (growth disorder of the tibia (shin bone) that causes the lower leg to angle inward, resembling a bowleg)
20-29:
n/a
30-39:
n/a
40-49:
- Arthralgia (joint pain)
- Joint swelling
- Loss of consciousness
- Muscle spasms (muscle contraction)
50-59:
- Portal vein thrombosis (venous thrombosis affecting the hepatic portal vein)
60+:
n/a
What are the existing conditions these people have? *
- Respiratory Disorder (respiratory disease): 3 people, 25.00%
- Pneumonia: 3 people, 25.00%
- Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 3 people, 25.00%
- Lung Disorder (lung disease): 3 people, 25.00%
- Dyspnea (difficult or laboured breathing): 3 people, 25.00%
- Bleeding Disorders: 1 person, 8.33%
- Asthma: 1 person, 8.33%
- Angioedema (rapid swelling of the dermis): 1 person, 8.33%
- Abnormal Behavior: 1 person, 8.33%
* Approximation only. Some reports may have incomplete information.
Do you take Xyzal and Fenoterol hydrobromide?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Xyzal (21,479 reports)
- Fenoterol hydrobromide (1,327 reports)
Browse all drug interactions of Xyzal and Fenoterol hydrobromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Xyzal:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Fenoterol hydrobromide:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Xyzal and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Fenoterol hydrobromide and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on levocetirizine dihydrochloride and fenoterol hydrobromide (the active ingredients of Xyzal and Fenoterol hydrobromide, respectively), and Xyzal and Fenoterol hydrobromide (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
No recent updates.